Anjali Sharma

For driven individuals searching for a more positive attitude, Success Mindsets is an anthology highlighting the thought process, attitude and approach to your professional life. The difference between success and failure is how you view a problem. WHAT'S THE NUMBER ONE DRIVER OF A SUCCESS MINDSET? FIND OUT NOW IN THE LATEST MIND-BOGGLING ANTHOLOGY FROM LEADERS PRESS The world prizes success. It rarely shows the effort people make to achieve it. We crave success, but it can seem so unattainable that we assume it's not for us. What if successful business people were to let us in on their secrets? That what separates the adored from the overlooked is mindset. You will come to understand this by reading the brilliant contributors of Success Mindsets. This anthology gathers advice from several dozen exceptional leaders, ranging from CEOs to champions to game-changers. Success Mindsets reveals that many roads lead to success and you must choose the one that suits your concept best. Each chapter in Success Mindsets will reveal methods for developing the right approach for navigating your journey to success. Dive in now to: Understand the mindset of being adaptable in your pursuit of success. Adopt a growth mindset, to value long-term growth over short-term revenue. Utilize your driven mindset to keep advancing your career even as the world turns completely upside down. Study areas of strength and bolster weaknesses through the mindset of lifelong learning. Embrace the mindset of self-compassion to look out for yourself while leading others. Minds are more effective when they are open. You can always adapt your mindset to the situation in pursuit of your goals. What mindset will shepherd you through your professional journey? Change your mind for the better. Order your copy of Success Mindsets today

In today's connection economy, the most successful leaders inspire their people with purpose and meaning. Powerful corporate storytelling can mobilise people around an organisational objective in a way that a focus on market share never will. Be it a digital transformation or a diversity and inclusion initiative, corporate change needs the support of the people in that organisation in order to stick.Yet, while all stories can move people to take action, storytelling isn't a one size fits all. The most effective influencers learn to flex their narrative based on the audience's time or their level of expertise.A story that works on the stage doesn't work in the boardroomA story that works in the boardroom doesn't work in a team meetingA story that works in a team meeting doesn't work in a one-to-one conversation A story that works in one-to-one conversation doesn't work in sales...Anjali Sharma introduces leaders and ambitious influencers to the Who, Why and How of strategic storytelling in business, enabling them bring about change and drive corporate success by telling exactly the right story in the right way.

Dans le paysage volutif de la science des mat riaux, les mat riaux Biosmart repr sentent une perc e l'intersection de la biologie, de la technologie et de la durabilit . Ces mat riaux avanc s sont con us pour interagir intelligemment avec les environnements biologiques, offrant des applications r volutionnaires en dentisterie, m decine, ing nierie tissulaire, administration de m dicaments et dispositifs biom dicaux.Cet ouvrage pr sente les derni res avanc es en mati re de mat riaux biocompatibles, bioactifs et stimuli-r actifs, en soulignant leur r le transformateur dans l'am lioration des r sultats des soins de sant . Les lecteurs exploreront des sujets tels que les biomat riaux issus de la nanotechnologie, les polym res auto-cicatrisants, les alliages m moire de forme et les surfaces antimicrobiennes, qui red finissent les soins aux patients et les applications cliniques.En mettant l'accent sur la recherche, l'innovation et les applications dans le monde r el, Biosmart Materials est une ressource essentielle pour les tudiants, les chercheurs, les cliniciens et les professionnels de l'industrie qui cherchent comprendre et exploiter la puissance des biomat riaux de la prochaine g n ration.

In the evolving landscape of material science, Biosmart Materials represent a breakthrough at the intersection of biology, technology, and sustainability. These advanced materials are engineered to interact intelligently with biological environments, offering revolutionary applications in dentistry, medicine, tissue engineering, drug delivery, and biomedical devices.This book delves into the latest advancements in biocompatible, bioactive, and stimuli-responsive materials, highlighting their transformative role in enhancing healthcare outcomes. Readers will explore topics such as nanotechnology-driven biomaterials, self-healing polymers, shape-memory alloys, and antimicrobial surfaces, which are redefining patient care and clinical applications.With a focus on research, innovation, and real-world applications, Biosmart Materials is an essential resource for students, researchers, clinicians, and industry professionals seeking to understand and harness the power of next-generation biomaterials.

Ce livre est une humble tentative d' valuation objective et critique de l'influence des c l brit s sur le comportement des consommateurs. Il s'int resse la mani re dont un consommateur se comporte sur le march l' gard des marques soutenues par des c l brit s. Dans le cas de l'Inde, la plupart des c l brit s sont issues du monde du cin ma, du sport et de la t l vision. Dans cette tude, leur impact sur les consommateurs est analys en tenant compte de huit de leurs attributs, savoir l'attrait, la controverse, la cr dibilit , le sexe, la performance, la popularit , la profession et le territoire. Le comportement des consommateurs est tudi l' gard d'une s lection de dix marques soutenues par des c l brit s dans diverses cat gories de produits et de services. La pr sente tude analyse en d tail les diff rentes dimensions du comportement des consommateurs de la r gion de Shekhawati, dans l' tat indien du Rajasthan, qui comprend les trois districts de Churu, Jhunjhunu et Sikar. Des outils statistiques ont t utilis s pour l'analyse quantitative des donn es collect es par le biais d'une enqu te et des conclusions ont t tir es.

Anjali Sharma'nın "Hint Mutfağı" adlı kitabı, Hint yemeklerinin mistik d nyasına dair bir keşif sunuyor. Bu kitap, Hint mutfağına meraklı olanlar i in hazırlanmış, geleneksel Hint yemeklerinin tariflerini ve Hint yemek k lt r n i eren zengin bir kaynak.Kitap, Hint mutfağına ait zenle se ilmiş yemek tarifleri ile birlikte, Hint mutfağına dair merak edilen tarihi, k lt rel ve coğrafi detayları okuyucularına sunuyor. Okuyucular, Hint yemek k lt r ne ait detayları ğrenirken, aynı zamanda kendi mutfaklarına Hint esintileri katmak i in g l bir kaynak elde edecekler.Anjali Sharma, Hint yemeklerine olan tutkusunu ve uzmanlığını bu kitapta bir araya getirerek, Hint yemek k lt r n keşfetmek isteyen herkes i in bir rehber sunuyor. Kitap, Hindistan'ın farklı b lgelerine ait zg n yemek tariflerinin yanı sıra, Hint yemek k lt r n n geleneklerini ve hikayelerini de i eriyor."Hint Mutfağı", okuyuculara Hint yemek k lt r n keşfetme fırsatı sunarken, aynı zamanda Hint baharatları ile yemek yapma konusunda da yardımcı oluyor. Bu kitap, Hint yemekleri ile dolu bir lezzet yolculuğuna ıkmanızı sağlayacak.

Die Prozessvalidierung von Darreichungsformen ist eine der wichtigsten regulatorischen Anforderungen f r die pharmazeutische Industrie. Sie zeigt den dokumentierten Nachweis ber die Qualit t des Produkts durch die Validierung des gesamten Herstellungsprozesses. Laut USFDA ist die Prozessvalidierung die Sammlung und Auswertung von Daten von der Entwurfsphase bis zur Produktion, die den wissenschaftlichen Nachweis erbringen, dass ein Prozess in der Lage ist, durchg ngig Qualit tsmerkmale zu liefern. Das Ziel der aktuellen Studie war die prospektive Validierung des Herstellungsprozesses von Tabletten des Medikaments X und die Sicherstellung, dass das Produkt die vorgegebenen Spezifikationen und Qualit tsmerkmale gem den FDA- und cGMP-Anforderungen erf llt. Um dieses Ziel zu erreichen, wurde ein robustes Validierungsprotokoll entworfen, in dem kritische Prozessparameter identifiziert wurden. Bestimmte routinem ige prozessbegleitende Bewertungstests und Challenge-Studien wurden durchgef hrt. Auch Tests am fertigen Produkt wurden durchgef hrt.

A valida o do processo da forma de dosagem um dos requisitos regulamentares mais importantes para a ind stria farmac utica. Apresenta provas documentais sobre a qualidade do produto atrav s da valida o de todo o processo de fabrico. De acordo com a USFDA, a valida o do processo a recolha e avalia o de dados, desde a fase de concep o at produ o, que estabelece provas cient ficas de que um processo capaz de fornecer consistentemente atributos de qualidade. O objectivo do presente estudo foi validar prospectivamente o processo de fabrico de comprimidos do medicamento X e assegurar que o produto cumpre as especifica es pr -determinadas e os atributos de qualidade de acordo com os requisitos da FDA e das cGMP. Para atingir o referido objectivo, foi concebido um protocolo de valida o robusto em que foram identificados os par metros cr ticos do processo. Foram efectuados alguns testes de avalia o de rotina durante o processo e estudos de desafio. Tamb m foram efectuados testes ao produto acabado.

La validation du processus de dosage est l'une des exigences r glementaires les plus importantes pour l'industrie pharmaceutique. Elle fournit des preuves document es de la qualit du produit en validant l'ensemble du processus de fabrication. Selon l'USFDA, la validation des proc d s est la collecte et l' valuation de donn es, depuis la conception jusqu' la production, qui tablissent la preuve scientifique qu'un proc d est capable de fournir des attributs de qualit de mani re constante. L'objectif de la pr sente tude tait de valider de mani re prospective le processus de fabrication des comprim s du m dicament X et de s'assurer que le produit r pond aux sp cifications pr d termin es et aux attributs de qualit conform ment aux exigences de la FDA et des BPF. Pour atteindre cet objectif, un protocole de validation robuste a t con u, dans lequel les param tres critiques du processus ont t identifi s. Certains tests d' valuation de routine en cours de processus et des tudes de provocation ont t r alis s. Des tests sur le produit fini ont galement t effectu s.